Major Probable

Açıklama

Spironolactone increases renal lithium reabsorption by promoting distal tubular sodium retention, leading to lithium toxicity.

Mekanizma

Spironolactone antagonizes aldosterone-mediated distal tubular sodium excretion; the resulting sodium retention reduces compensatory proximal tubular sodium (and lithium) reabsorption variably, but overall lithium levels tend to rise.

Klinik Önemi

Lithium toxicity has been documented with spironolactone co-administration; the direction and magnitude of interaction is variable.

Yönetim

Monitor lithium levels within 1 week of spironolactone initiation or dose change; adjust lithium dose based on levels.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.